Atosiban Acetate
Oxytocin antagonist for preterm labor inhibition. Selective vasopressin V1a and oxytocin receptor antagonist for tocolysis in threatened preterm delivery.
Atosiban Acetate is a synthetic nonapeptide and a competitive oxytocin receptor antagonist used for the management of preterm labor. It selectively binds to oxytocin receptors on the myometrium, inhibiting oxytocin-induced uterine contractions without affecting systemic hemodynamics, providing a safe and effective tocolytic therapy to delay delivery in threatened preterm birth.
| Parameter | Specification |
| CAS | 90779-69-4 |
| Molecular Formula | C₄₃H₆₇N₁₁O₁₂S₂ |
| Molecular Weight | 1054.24 g/mol |
| Category | GnRH/Reproductive |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Preterm labor, tocolysis, uterine contraction inhibition |
| CAS | 90779-69-4 |
|---|---|
| Applications | Fetal Protection, Obstetric Emergency, Oxytocin Antagonist, Preterm Labor Inhibition, |
Related products
-
Leuprorelin Acetate
CAS: 74381-53-6Applications: Breast Cancer, Endometriosis, Precocious Puberty, Prostate Cancer -
Orforglipron
CAS: 2212020-52-3Applications: obesity management, Oral GLP-1 Development, Type 2 diabetes -
Liraglutide
CAS: 204656-20-2Applications: cardiovascular risk reduction, GLP-1, obesity management -
Dulaglutide
CAS: 923950-08-7